Adrenocortical carcinoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
(2 intermediate revisions by the same user not shown)
Line 6: Line 6:
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*Adrenocortical carcinoma is a rare [[cancer]], with [[incidence]] of 10-20 per 100,000 population annually.<ref name="DeVita">{{cite book |author=edited by Vincent T. DeVita, Samuel Hellman, Steven A. Rosenberg |title=Cancer: principles & practice of oncology |publisher=Lippincott-Raven |location=Philadelphia |year=2005 |pages=|isbn=0-7817-4865-8 |oclc= |doi=}}</ref><ref name="UTDACC">{{cite web | last =Savarese | first =Diane MF |author2=Lynnette K Nieman| title =Clinical presentation and evaluation of adrenocortical tumors| work =UpToDate Online v. 15.1| publisher =UpToDate| date = 2006-08-08| url =http://www.uptodateonline.com/utd/content/topic.do?topicKey=adrenal/17707&type=A&selectedTitle=1~16 | accessdate =2007-06-05}}</ref>
*Adrenocortical carcinoma is a rare [[cancer]], with [[incidence]] of 0.1-0.2 per 100,000 individuals annually.
===Age===
===Age===
*Adrenocortical carcinoma has a [[bimodal distribution]] by age, with cases clustering in children under 6, and in adults 30-40 years old.<ref name="DeVita"/>
*Adrenocortical carcinoma has a [[bimodal distribution]] by age, with cases clustering in children under 6, and in adults 30-40 years old.


==References==
==References==

Revision as of 21:22, 27 August 2015

Adrenocortical carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenocortical carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

MRI

CT

Ultrasound

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Radiation Therapy

Primary prevention

Secondary prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Study

Case #1

Adrenocortical carcinoma epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adrenocortical carcinoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adrenocortical carcinoma epidemiology and demographics

CDC on Adrenocortical carcinoma epidemiology and demographics

Adrenocortical carcinoma epidemiology and demographics in the news

Blogs on Adrenocortical carcinoma epidemiology and demographics

Hospitals Treating Adrenocortical carcinoma

Risk calculators and risk factors for Adrenocortical carcinoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]Ahmad Al Maradni, M.D. [3]

Overview

Adrenocortical carcinoma is a rare cancer that tends to affect children and young adults.

Epidemiology and Demographics

Incidence

  • Adrenocortical carcinoma is a rare cancer, with incidence of 0.1-0.2 per 100,000 individuals annually.

Age

  • Adrenocortical carcinoma has a bimodal distribution by age, with cases clustering in children under 6, and in adults 30-40 years old.

References

Template:WikiDoc Sources